SEC Form 4 · accession 0001144204-17-028639
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy A Springer
Director
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 17, 2017 | P | 11,244 | $14.006 | A | 11,244 | D | |
| Common Stock | May 18, 2017 | P | 4,860 | $14.00 | A | 16,104 | D | |
| Common StockF2,F3 | holding | — | — | — | 1,237,028 | I | See Footnote | |
| Common StockF2,F4 | holding | — | — | — | 445,576 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.64 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2LKST, Inc. is the general partner of Leukon Investments LP. Timothy Springer is the president of LKST, Inc. and the managing member of TAS Partners, LLC. The Reporting Person disclaims beneficial ownership of the securities held by Leukon Investments LP and TAS Partners, LLC except to the extent of his pecuniary interest therein, if any.
- F3Held by Leukon Investments LP.
- F4Held by TAS Partners, LLC.